Posted by Michael Wonder on 25 Nov 2016
CADTH calls for input on submission for new medicine for patients with biliary cirrhosis
24 November 2016 - CADTH is calling for patient input on a pending submission from Intercept Pharmaceuticals for obeticholic acid.
Obeticholic acid is a new medicine for use in patients with primary biliary cirrhosis.
The submission is due on 22 December 2016.
